Sex Differences in Circulating Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels and Adverse Outcomes in Coronary Artery Disease.
Anurag Mehta,Shivang R. Desai,Yi‐An Ko,Chang Liu,Devinder S. Dhindsa,Aditi Nayak,Ananya Hooda,Mohamed A. Martini,Kiran Ejaz,Laurence S. Sperling,Jochen Reiser,Salim S. Hayek,Arshed A. Quyyumi
DOI: https://doi.org/10.1161/JAHA.119.015457
IF: 6.106
2020-02-25
Journal of the American Heart Association
Abstract:Background Women have higher circulating levels of soluble urokinase‐type plasminogen activator receptor (suPAR), and elevated suPAR is associated with cardiovascular risk. The independent association of sex with suPAR and the impact of sex on its association with cardiovascular risk are unknown. Methods and Results Plasma suPAR was measured using ELISA in 2 cohorts of 666 asymptomatic individuals (49 years, 65% women) and 4184 patients with coronary artery disease (63 years, 37% women). Independent association of sex with suPAR was studied using linear regression models adjusted for demographics, risk factors, and visceral adiposity in asymptomatic participants. Impact of sex on association of suPAR with all‐cause mortality was studied in patients with coronary artery disease using multivariable‐adjusted Cox models. Sex‐specific suPAR cutoffs for predicting all‐cause mortality were calculated. Asymptomatic women had 10% higher suPAR compared with men after adjusting for confounders, and visceral adiposity partly accounted for this association. Over a median follow‐up of 5.2 years, 795 deaths were recorded in patients with coronary artery disease. Log 2 ‐transformed suPAR was independently associated with mortality (hazard ratio per 1‐SD 1.72, 95% CI 1.60–1.85) and an interaction with sex was noted ( P =0.005). Association of suPAR with mortality was slightly weaker in women (hazard ratio 1.61, 95% CI 1.41–1.83) compared with men (hazard ratio 1.83, 95% CI 1.67–2.00). However, using sex‐specific suPAR cut‐offs (4392 pg/mL for women and 3187 pg/mL for men), a similar mortality incidence was observed for both sexes (38.5% and 35.5%, respectively, P =0.3). Conclusions Women have 10% higher plasma suPAR levels compared with men. Elevated sex‐specific plasma suPAR levels are equally predictive of risk of adverse events in both sexes. Clinical Perspective What Is New? Asymptomatic women and those with coronary artery disease have higher plasma soluble urokinase‐type plasminogen activator receptor, a marker of systemic immune activation, as compared with men. However, the association of elevated plasma soluble urokinase‐type plasminogen activator receptor level with adverse cardiovascular outcomes is similar for women and men with coronary artery disease when sex‐specific cut‐offs are used. What Are the Clinical Implications? Cardiovascular risk assessment tools incorporating suPAR as a risk predictor will likely require sex‐specific algorithms for creating prediction models. Introduction Coronary artery disease (CAD) is the leading cause of mortality worldwide. 1 The existing cardiovascular risk assessment paradigms in the general population and among those with CAD involve ascertainment of high‐risk clinical characteristics that are associated with adverse outcomes. 2 , 3 , 4 These approaches are imperfect and do not capture the effect of subclinical inflammation and immune activation that are integral to the pathobiology of atherosclerosis. 5 In this context, novel circulating protein‐based, inflammatory biomarkers hold a promising role for stratifying cardiovascular risk. 6 Soluble urokinase‐type plasminogen activator receptor (suPAR), a marker of systemic immune activation, inflammation, and thrombogenesis, is one such promising biomarker. 7 SuPAR is typically cleaved off the plasma membrane by the enzymatic processing of the glycosyl‐phosphatidylinositol–anchor in podocytes, immature myeloid cells, vascular endothelial cells, and activated T‐lymphocytes. 8 , 9 Both membrane‐bound and soluble forms regulate cell adhesion and migration by interacting directly with integrins, and the soluble form's chemotactic properties play a role in recruiting granulocytes, mobilizing hematopoietic stem cells, and in podocyte detachment. 10 , <a cl -Abstract Truncated-
cardiac & cardiovascular systems